Membrane phospholipid composition specific liposome for promoting eggshell mineralization and application thereof
By developing membrane phospholipid composition-specific liposomes that mimic the phospholipid characteristics of uterine vesicle membranes in laying hens, the problem of imprecise regulation of the eggshell mineralization microenvironment in existing technologies has been solved, resulting in improved eggshell strength and reduced egg breakage rate, with good biocompatibility and targeting.
Patent Information
- Application Number
- CN202511727928.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-11-24
- Publication Date
- 2026-01-13
AI Technical Summary
Existing technologies cannot precisely regulate the microenvironment of eggshell mineralization, leading to decreased eggshell strength and increased egg breakage rate. Existing improvement measures are lagging and unstable, and there is a lack of specialized liposome formulations targeting the eggshell mineralization interface.
A membrane phospholipid composition-specific liposome was developed to mimic the phospholipid characteristics of the uterine vesicle membrane in laying hens. It contains key membrane phospholipids such as PC, PE, PS, and PA, and is combined with DSPE-PEG and cholesterol. It is induced to undergo mineralization and nucleation and regulate the expression of mineralization-related genes through an in vitro mineralization system.
It successfully simulates the initial microenvironment of mineralization in organisms, promotes the formation of calcium carbonate crystal nuclei, and improves eggshell strength. It shows good biocompatibility and stability, can be targeted and taken up by uterine epithelial cells of laying hens, significantly upregulates the expression of mineralization-related genes, and improves eggshell mineralization efficiency.
Smart Images

Figure CN121313562A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the fields of poultry production, biomineralization regulation and nanoliposome formulations, specifically relating to a membrane phospholipid composition-specific liposome that promotes eggshell mineralization and its application. Background Technology
[0002] Eggshell quality is one of the core economic traits in laying hen production, directly affecting the mechanical strength, breakage rate, storage and transportation stability, and processing suitability of commercial eggs. Eggshell formation mainly occurs in the uterine region of the oviduct, and its mineralization process includes three stages: inorganic ion transmembrane transport, primary crystal nucleus formation, and ordered crystal growth. Among these, uterine fluid-derived vesicles play a crucial role in crystal nucleus induction and the construction of the primary mineralization interface. The phospholipid bilayer on the vesicle membrane surface not only participates in calcium ion enrichment and the shaping of the interfacial charge environment, but also, together with carbonic anhydrase, shell membrane proteins, and shell gland epithelial secretory factors, regulates the morphology and arrangement of calcium carbonate crystals, forming the structural basis for maintaining eggshell density and crack resistance.
[0003] As the laying cycle lengthens and laying hens transition to the later stages of egg production, decreased eggshell strength and increased breakage rates are common occurrences. Previous studies have largely attributed this to insufficient calcium and phosphorus supply or decreased expression of mineralization factors. Recent research has found that uterine exocrine vesicles are closely related to eggshell mineralization capacity.
[0004] Existing measures to improve eggshell quality, such as increasing calcium and phosphorus supply, supplementing with vitamin D or trace elements, and using plant extracts or probiotics, all rely on host absorption and physiological regulation. These methods are characterized by lag and unstable effects, and cannot precisely target the eggshell mineralization microenvironment, resulting in a lack of spatial and component specificity in mineralization regulation. Current liposome or microencapsulation technologies are primarily used for drug delivery or health supplements; no specific liposome formulations targeting the eggshell mineralization interface have yet been discovered.
[0005] Therefore, developing a membrane phospholipid composition-specific liposome that mimics the phospholipid characteristics of uterine vesicle membranes in laying hens and regulates mineralization nucleation has become an important technical requirement for improving eggshell mineralization efficiency. Summary of the Invention
[0006] By comparing the lipidome of uterine fluid exocrine vesicles in age-induced high and low eggshell strength groups, the inventors found that key membrane phospholipid components such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidyl acid (PA) were consistently reduced in the low eggshell strength group (as shown in Table 1). This change may weaken the negative charge density and calcium ion enrichment capacity of the vesicle surface, thereby reducing the crystal nucleus formation efficiency and affecting the subsequent dense crystal growth.
[0007] Table 1. Differences in lipid metabolites in uterine fluid vesicles during peak and late stages of egg production (late stage vs. peak stage)
[0008] To address the aforementioned technical problems, this invention provides a membrane phospholipid-specific liposome that promotes eggshell mineralization. This liposome can induce mineralization and crystal formation in the eggshell mineralization system and can be taken up by uterine epithelial cells of laying hens, regulating the expression of mineralization-related genes.
[0009] The technical solution adopted by the present invention to achieve the above objectives is as follows: A membrane phospholipid composition-specific liposome that promotes eggshell mineralization, the liposome membrane being made from a component comprising: (a) a core membrane phospholipid; (b) an acidic phospholipid; and (c) a membrane stabilizing component; The core membrane phospholipids include PC and PE; The acidic phospholipid is PS and / or PA; The membrane stabilizing components include at least one of methoxy polyethylene glycol modified phosphatidylethanolamine (DSPE-PEG), 1,2-dimyristic-rac-glycerol-3-methoxy polyethylene glycol (DMG-PEG), 1,2-dioleoyl-sn-glycerol-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)]] (DOPE-PEG), and cholesterol.
[0010] Further, the PC is at least one of egg-derived cleavage monoacyl lysophosphatidylcholine (Egg LYSO PC), 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcholine (POPC), and methionine phosphatidylcholine (Egg PC); The PE is at least one of egg-derived cleavage monoacyl lysophosphatidylethanolamine (Egg LYSO PE), 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylethanolamine POPE, and methionine phosphatidylethanolamine Egg PE; The PS is at least one of 1-stearoyl-2-oleoylphosphatidylserine (18:0-18:1 PS) and 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylserine (POPS); The PA is at least one of 1-palmitoyl-2-oleoylphosphatidic acid (16:0-18:1 PA) and 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphate (POPA); Furthermore, the components of the liposome membrane are in the following mass ratio: PC: PE: PS: PA: DSPE-PEG:Cholesterol = (5~6): (1~2): (0~1): (0~1): (0.5~0.7): (0.3~0.5); wherein PS and PA cannot both be 0.
[0011] Furthermore, the liposomes have a particle size of 150~250 nm and a zeta potential of -20 mV to -40 mV.
[0012] Furthermore, the liposomes are prepared by a thin-film hydration-ultrasound-membrane extrusion method.
[0013] The present invention also provides a method for preparing liposomes with specific membrane phospholipid composition as described above.
[0014] The method includes the following steps: weighing raw materials according to the mass ratio and dissolving them in an organic solvent to form a homogeneous lipid solution; rotary evaporating under reduced pressure to form a lipid membrane; adding an aqueous phase for hydration to obtain coarsely dispersed liposomes; and obtaining a liposome dispersion with uniform particle size through ultrasonic and membrane extrusion treatment.
[0015] The above steps can be routinely optimized by adjusting the hydration time, ultrasonic parameters, and extruded membrane pore size according to the target particle size and stability.
[0016] The application of the above-mentioned membrane phospholipid composition specific liposomes that promote eggshell mineralization in the preparation of formulations that regulate the biomineralization function of the uterus of laying hens also falls within the scope of protection of this invention.
[0017] Furthermore, the regulation of biomineralization function includes: inducing calcium carbonate mineralization nucleation and / or regulating the expression of mineralization-related genes in uterine epithelial cells.
[0018] Furthermore, the formulation is used to maintain or improve the initial mineralization microenvironment of the eggshell formation interface.
[0019] Compared with the prior art, the present invention has the following beneficial effects: 1. By specifically combining core membrane phospholipids (PC, PE) with acidic phospholipids (PS and / or PA), the microenvironment of initial mineralization in vivo was successfully simulated. In vitro mineralization experiments showed that the liposomes of this invention can effectively promote the formation and growth of calcium carbonate crystal nuclei, and exhibit excellent performance at interfaces such as eggshell membranes and silicon wafers, demonstrating their universality and effectiveness. 2. The liposomes are mainly constructed using egg-derived phospholipids and inherent biological components (cholesterol), exhibiting good biocompatibility. Cell uptake experiments have demonstrated that the liposomes can be effectively taken up by uterine epithelial cells of laying hens, clarifying their targeting ability at key sites of eggshell formation; 3. By introducing DSPE-PEG and cholesterol as membrane stabilizing components and optimizing the preparation process, a liposome dispersion with uniform particle size (150~250 nm) and stable zeta potential (-20 mV to -40 mV) was successfully prepared. It has good stability and is easy to store and apply in industrial applications. 4. Beyond simple physical induction, cell experiments showed that after the liposomes were taken up by cells, they could significantly upregulate key genes related to eggshell mineralization, thus confirming at the molecular level that they could actively regulate the biomineralization function of uterine epithelial cells. Attached Figure Description
[0020] Figure 1 The images show the transmission electron microscopy (TEM) morphology of the liposomes prepared in the embodiments and comparative examples of this invention.
[0021] Figure 2 The graph shows the particle size and zeta charge results of the liposomes prepared in the embodiments and comparative examples of this invention.
[0022] Figure 3 The images show the in vitro mineralization electron microscopy results of liposomes prepared in the embodiments and comparative examples of the present invention, using a silicon wafer as a substrate.
[0023] Figure 4 The images show the in vitro mineralization electron microscopy results of liposomes prepared in the embodiments and comparative examples of the present invention, with eggshell membrane as the substrate.
[0024] Figure 5 The graph shows the results of cell uptake of liposomes prepared in the embodiments and comparative examples of the present invention.
[0025] Figure 6 The graph shows the results of mineralization-related gene expression after cells take up the liposomes prepared in the embodiments and comparative examples of this invention. Detailed Implementation
[0026] The present invention will now be described in further detail with reference to specific embodiments. The given embodiments are merely illustrative of the invention and not intended to limit its scope. The embodiments provided below can serve as a guide for further improvements by those skilled in the art and do not constitute a limitation on the invention in any way.
[0027] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, performed according to the techniques or conditions described in the literature in this field or according to the product instructions. Unless otherwise specified, the materials and reagents used in the following examples are commercially available.
[0028] The raw materials used in the following examples and comparative examples are as follows: Egg LYSO PC, CAS No. 97281-36-2, Item No. 830071P, purchased from Sigma; Egg LYSO PE, CAS No. 97281-40-8, Item No. 860081P, purchased from Sigma; 18:0-18:1 PS, CAS No. 321883-23-2, Item No. 840039P, purchased from Sigma; 16:0-18:1 PA, CAS No. 169437-35-8, Item No. 840857P, purchased from Sigma; DSPE-PEG2000, part number R-1028-2K, purchased from Avanti Polar Lipids, Inc. Cholesterol, product number BD155660, purchased from Avanti Polar Lipids, Inc.; Triglycerides (TG (16:0 / 16:0 / 16:0)), product number R-BD155660, were purchased from Shanghai Bid Pharmaceutical Technology Co., Ltd.
[0029] Example 1: Preparation of a membrane phospholipid composition-specific liposome that promotes eggshell mineralization The membrane material consists of Egg LYSO PC, Egg LYSO PE, 18:0-18:1 PS, DSPE-PEG2000 and Cholesterol, in a mass ratio of 6:2:1:0.6:0.4.
[0030] Prepared by the following steps: S1. Weigh out 5 mg of the raw material according to the mass ratio and dissolve it in 2 mL of chloroform to form a homogeneous lipid solution; S2. The lipid solution is rotary evaporated under reduced pressure in a sample vial to form a lipid film; S3. Add deionized water and sonicate to obtain coarsely dispersed liposomes; S4. A uniform liposome dispersion was obtained by ultrasonic treatment and liposome extrusion (polycarbonate membrane, 100 nm pore size), and the volume was adjusted to a final concentration of 5 mg / mL.
[0031] Example 2: Preparation of a membrane phospholipid composition-specific liposome that promotes eggshell mineralization The membrane material consists of Egg LYSO PC, Egg LYSO PE, 16:0-18:1 PA, DSPE-PEG2000 and Cholesterol, in a mass ratio of 6:2:1:0.7:0.3.
[0032] The preparation steps are the same as in Example 1.
[0033] Example 3: Preparation of a membrane phospholipid composition-specific liposome that promotes eggshell mineralization The membrane material includes Egg LYSO PC, Egg LYSO PE, 18:0-18:1 PS, 16:0-18:1 PA, DSPE-PEG2000 and Cholesterol, in a mass ratio of 6:1:1:1:0.7:0.3.
[0034] The preparation steps are the same as in Example 1.
[0035] Example 4: Preparation of a membrane phospholipid composition-specific liposome that promotes eggshell mineralization The membrane material includes Egg LYSO PC, Egg LYSO PE, 18:0-18:1 PS, 16:0-18:1 PA, DSPE-PEG2000 and Cholesterol, in a mass ratio of 5:2:1:1:0.5:0.5.
[0036] The preparation steps are the same as in Example 1.
[0037] Comparative Example 1 Same as Example 1, except that TG (16:0 / 16:0 / 16:0) in the same mass ratio replaces 18:0-18:1 PS, that is, the membrane material includes Egg LYSO PC, Egg LYSO PE, TG (16:0 / 16:0 / 16:0), DSPE-PEG2000 and Cholesterol, in a mass ratio of 6:2:1:0.6:0.4.
[0038] Comparative Example 2 Same as Example 3, except that Egg LYSO PE is not added, but only the same mass ratio of Egg LYSO PC is increased. That is, the membrane material includes Egg LYSO PC, 18:0-18:1 PS, 16:0-18:1 PA, DSPE-PEG2000 and Cholesterol, in a mass ratio of 7:1:1:0.7:0.3.
[0039] Material characterization I. Experimental Methods The morphology of the examples and comparative samples was observed using transmission electron microscopy (TEM). After ultrasonic dispersion in ultrapure water, the samples were dropped onto a carbon film copper mesh support, allowed to dry naturally at room temperature, and then placed under a TEM for imaging observation.
[0040] The particle size and Zeta potential of the liposomes in the examples and comparative examples were determined using a NanoBrook 90Plus PALS particle size potentiometer. Prepared liposome samples were gently filtered through a 0.22 μm filter membrane to remove large particles. The samples were diluted with deionized water at a 1:10 volume ratio, mixed thoroughly, and added to disposable optical cuvettes. Refractive index and viscosity parameters were set, and dynamic light scattering was performed at 25 °C. The average particle size (Z-average) and polydispersity index (PDI) were recorded. Samples were diluted in the same manner, added to a dedicated Zeta electrode cell, and electrophoresis mode was set. Electrophoretic light scattering was performed at 25 °C, and the potential (mV) was recorded. Each sample was measured in triplicate, and the results are expressed as mean ± standard deviation.
[0041] II. Experimental Results The results of transmission electron microscopy observation are as follows Figure 1 As shown, all embodiments and comparative examples formed spherical nanoliposome particles with relatively uniform particle size distribution.
[0042] Particle size, potential, and DPI (polydispersity index) results are as follows: Figure 2 As shown, the particle size distribution of the liposomes in each embodiment and comparative example ranges from 150 to 250 nm; the DPI value ranges from 0.1 to 0.2, indicating a relatively uniform particle size distribution; and the Zeta potential ranges from -20 to -40 mV, further demonstrating the stability of the liposomes.
[0043] Example 5: In vitro mineralization experiment I. Experimental Methods 1. Experimental Grouping This study used eggshells and silicon wafers as mineralization substrates. The liposome mineralization reaction solution was prepared by mixing 100 μL of 40 mM calcium chloride solution with 100 μL of liposome solution by pipetting. Eight treatment groups were set up: a control group (with ultrapure water), a calcium chloride group (with 20 μL of calcium chloride solution), Examples 1-4, and Comparative Examples 1 and 2. The Examples and Comparative Examples groups received a combination of 10 μL of the corresponding liposome solution and 10 μL of calcium chloride solution.
[0044] 2. Mineralization treatment The mineralization experiment was conducted at room temperature. The prepared mineralization reaction solution was dropped onto the surface of an eggshell or silicon wafer, ensuring it evenly covered the mineralization substrate. The incubation time was 12 h. After incubation, unbound ions or liposome components were gently washed away, and the wafers were allowed to air dry at room temperature for subsequent morphology and mineralization product characterization.
[0045] 3. Crystal morphology The size and morphology of calcium carbonate crystals grown in vitro were observed using a scanning electron microscope (SEM, SU8020, Hitachi, Japan). When eggshells were used as the mineralization substrate, the crystals were observed at 700x and 5000x magnification; when silicon wafers were used as the mineralization substrate, the crystals were observed at 300x magnification.
[0046] II. Experimental Results SEM results of in vitro mineralization are as follows Figure 3 (Using silicon wafers as substrates) and Figure 4 (Using the eggshell membrane as a substrate). In the calcium chloride solution treatment group, smooth, regularly square crystals were formed, exhibiting a typical "homogeneous nucleation" phenomenon. This reflects the free growth and isotropy of crystals under clean, undisturbed solution and equilibrium conditions. The final structure tends to be parallel, lacking anchoring and mechanical interlocking, leading to increased eggshell brittleness and poor toughness. In contrast, the calcium carbonate crystal particles formed in all examples and comparative treatment groups were irregular and had rough surfaces. This "heterogeneous nucleation" reflects the intervention of the organic matrix on calcium and carbonate ions, simultaneously promoting mineralization at multiple sites. Due to the different growth rates of crystals in different directions, irregular mineral particles were formed, providing a larger contact area and forming an interlocking structure. This structure can effectively prevent crack propagation under external impact. Compared with the examples, the comparative group had fewer and smaller crystals, indicating that the lack of Egg LYSO PE or 18:0-18:1 PS and 16:0-18:1 PA significantly slowed down the initiation of mineralization and the crystal growth rate. In the four embodiments, the number of crystals in Example 2 was significantly reduced, and some crystals exhibited a "homogeneous nucleation" phenomenon, suggesting the importance of 18:0-18:1 PS in maintaining the number of crystal nuclei. Examples 3 and 4 showed better nucleation numbers and heterogeneity, with Example 3 exhibiting the largest crystal size, indicating that the synergistic effect of Egg LYSO PC, Egg LYSO PE, 18:0-18:1 PS, and 16:0-18:1 PA had the strongest promoting effect on the mineralization process.
[0047] Example 6: Cell Uptake Experiment I. Experimental Methods 1. Liposome fluorescent labeling PKH67 was used to fluorescently label liposomes. 40 μL of liposomes from each group and 60 μL of PBS were placed in a 1.5 mL sterile centrifuge tube, while the control group received 100 μL of PBS. Then, 500 μL of Diluent C solution was added to each centrifuge tube and gently mixed. In another 1.5 mL sterile centrifuge tube, 4 μL of PKH67 staining solution and 500 μL of Diluent C solution were added and gently mixed. The mixture was centrifuged at 16,000 ×g for 5 min, and the supernatant was collected and transferred to a new 1.5 mL sterile centrifuge tube. The PKH67 staining solution and liposome solution were mixed and incubated at room temperature in the dark for 5 min. Then, 200 μL of 1% BSA-PBS was added to terminate the staining reaction. The mixture was transferred to an ultracentrifuge tube, PBS was added to balance the solution, and the mixture was centrifuged at 110,000 ×g for 90 min. Discard the supernatant, resuspend the precipitate in 1 mL PBS, balance the mixture, centrifuge again at 110,000 × g for 90 min, discard the supernatant, resuspend the liposomes in 100 μL PBS, and store in the dark for later use.
[0048] 2. Cell uptake experiment Egg-laying hen uterine epithelial cells were used at a concentration of 1×10 6 Cells / wells were seeded at a density suitable for incubation in 6-well plates for 24 h. The medium was then replaced with serum-free medium containing either PKH67-labeled or unlabeled liposomes (final concentration 10 μg / mL) and incubated for another 6 h. After treatment, cells were washed with PBS, fixed with immunofluorescence fixative at room temperature for 20 min, the fixative was discarded, and the cells were washed three times with PBS. Cells were kept moist with 500 μL of PBS, and their uptake of liposomes was observed and recorded using a fluorescence microscope.
[0049] II. Experimental Results The uptake of liposomes by chicken uterine epithelial cells is as follows: Figure 5 As shown, the liposomes in each embodiment and comparative example were effectively taken up by cells, demonstrating good biocompatibility. In terms of fluorescence intensity, the uptake effect of Example 3 was better.
[0050] Example 7: Expression of Cellular Mineralization Genes I. Experimental Methods Chicken uterine epithelial cells were treated with no treatment, as well as in Examples 1, 2, and 3. Total RNA was extracted using the EasyPure RNA Extraction Kit (TransGen Biotech, Beijing, China). RNA concentration was determined using an Epoch microplate spectrophotometer (BioTek, USA). Reverse transcription was performed using First-Strand cDNA Synthesis Ultramix Reagent (TransGen Biotech, Beijing, China). Quantitative PCR was performed on a CFX96 C1000™ thermal cycler (Bio-Rad, USA) using the SYBR Green assay in triple replicates. Relative gene expression was measured using 2... -ΔΔCt Method calculation.
[0051] II. Experimental Results Expression of mineralization-related genes in chicken uterine epithelial cells after liposome treatment, such as Figure 6 As shown, compared with the untreated control, Examples 1 and 3 significantly upregulated the gene expression of osteocalcin OC-116 and sodium channel protein SCNN1G. Example 3 also significantly upregulated the expression of SCNN1A and SCNN1B, suggesting that the membrane phospholipid composition-specific liposomes of the present invention can synergistically promote calcium ion transmembrane transport and improve mineralization efficiency by regulating sodium channel and osteocalcin expression.
[0052] The present invention has been described in detail above. Those skilled in the art will recognize that the invention can be practiced in a wide range of ways with equivalent parameters, concentrations, and conditions without departing from its spirit and scope, and without requiring unnecessary experiments. While specific embodiments have been provided, it should be understood that further modifications can be made to the invention. In summary, according to the principles of the invention, this application is intended to include any changes, uses, or improvements to the invention, including changes made using conventional techniques known in the art that depart from the scope disclosed herein.
Claims
1. A membrane phospholipid composition-specific liposome, said liposome membrane being made from a component comprising: (a) a core membrane phospholipid; (b) an acidic phospholipid; and (c) a membrane stabilizing component; in, The core membrane phospholipids contain PC and PE; The acidic phospholipid is PS and / or PA; The membrane stabilizing components include at least one of methoxy polyethylene glycol modified phosphatidylethanolamine, 1,2-dimyristic-rac-glycerol-3-methoxy polyethylene glycol, 1,2-dioleoyl-sn-glycerol-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)], and cholesterol.
2. The liposomes according to claim 1, characterized in that, The PC is at least one of egg-derived cleavage monoacyl lysophosphatidylcholine Egg LYSO PC, 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcholine POPC, and methionin Egg PC; The PE is at least one of egg-derived cleavage-type monoacyl lysophosphatidylethanolamine Egg LYSO PE, 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylethanolamine POPE, and methionine phosphatidylethanolamine Egg PE; The PS is at least one of 1-stearoyl-2-oleoylphosphatidylserine 18:0-18:1 PS and 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylserine POPS; The PA is at least one of 1-palmitoyl-2-oleoylphosphatidyl 16:0-18:1 PA and 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphate POPA.
3. The liposomes according to claim 1, characterized in that, The components of the liposome membrane are in the following mass ratio: PC: PE: PS: PA: DSPE-PEG: Cholesterol = (5~6): (1~2): (0~1): (0~1): (0.5~0.7): (0.3~0.5); wherein PS and PA cannot both be 0.
4. The liposomes according to claim 1, characterized in that, The liposomes have a particle size of 150~250 nm and a zeta potential of -20 mV to -40 mV.
5. A method for preparing liposomes according to any one of claims 1-4, comprising the following steps: weighing raw materials according to a mass ratio and dissolving them in an organic solvent to form a homogeneous lipid solution; rotary evaporating under reduced pressure to form a lipid membrane; adding an aqueous phase for hydration to obtain coarsely dispersed liposomes; and obtaining a liposome dispersion with uniform particle size by ultrasonic and membrane extrusion treatment.
6. The use of membrane phospholipid composition-specific liposomes according to any one of claims 1-4 in the preparation of formulations that regulate the biomineralization function of the uterus in laying hens.
7. The application according to claim 6, characterized in that, The regulation of biomineralization functions includes: inducing calcium carbonate mineralization nucleation and / or regulating the expression of mineralization-related genes in uterine epithelial cells.
8. The application according to claim 6, characterized in that, The formulation is used to maintain or improve the initial mineralization microenvironment at the eggshell formation interface.
